CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tumor Biology

• Publication date

  2014-08-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-014-2370-6PMID 25085583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

  2014cited by this paper
• Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients

  2013cited by this paper
• Molecular mechanisms of melatonin’s inhibitory actions on breast cancers

  2013cited by this paper
• Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

  2013cited by this paper
• Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.

  2013cited by this paper
• SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.

  2013cited by this paper
• Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas

  2013cited by this paper
• DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erbα

  2013cited by this paper
• Melatonin reverses tunicamycin‐induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing Survivin

  2013cited by this paper
• Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR‐induced depletion, and protects against the formation of DNA damage (8‐hydroxy‐2'‐deoxyguanosine) in ex vivo human skin

  2013cited by this paper
• Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review

  2013cited by this paper
• The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

  2012cited by this paper
• Melatonin potentiates chemotherapy‐induced cytotoxicity and apoptosis in rat pancreatic tumor cells

  2012cited by this paper
• DBIRD integrates alternative mRNA splicing with RNA polymerase II transcript elongation

  2012cited by this paper
• Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells

  2012cited by this paper
• Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma

  2012cited by this paper
• Amelioration of melatonin on oxidative stress and genotoxic effects induced by cisplatin in vitro

  2012cited by this paper
• DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.

  2012cited by this paper
• Regulation of SIRT1 activity by genotoxic stress.

  2012cited by this paper
• Role of Deleted in Breast Cancer 1 (DBC1) Protein in SIRT1 Deacetylase Activation Induced by Protein Kinase A and AMP-activated Protein Kinase*

  2012cited by this paper
• Natural compounds as inducers of cell death

  2012cited by this paper
• Melatonin synergistically enhances cisplatin‐induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK‐OV‐3 cells

  2012cited by this paper
• Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.

  2012cited by this paper
• Melatonin suppresses doxorubicin‐induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction

  2012cited by this paper
• Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator

  2011cited by this paper
• Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

  2011cited by this paper
• The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop

  2011cited by this paper
• Melatonin in Mitochondrial Dysfunction and Related Disorders

  2011cited by this paper
• Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy

  2011cited by this paper
• Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.

  2010cited by this paper
• Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.

  2010cited by this paper
• DBC-1 mediates endocrine resistant breast cancer cell survival

  2010cited by this paper
• Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.

  2010cited by this paper
• Repression of estrogen receptor beta function by putative tumor suppressor DBC1.

  2010cited by this paper
• Balance between SIRT1 and DBC1 expression is lost in breast cancer

  2010cited by this paper
• HDAC3 Is Negatively Regulated by the Nuclear Protein DBC1*

  2010cited by this paper
• SIRT1 regulates UV-induced DNA repair through deacetylating XPA.

  2010cited by this paper
• Identification of DBC1 as a transcriptional repressor for BRCA1

  2010cited by this paper
• Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells.

  2010cited by this paper
• Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model

  2010cited by this paper
• Effect of melatonin on human keratinocytes and fibroblasts subjected to UVA and UVB radiation In vitro.

  2009cited by this paper
• Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity*

  2009cited by this paper
• Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation*

  2009cited by this paper
• Molecular Mechanisms of Melatonin Anticancer Effects

  2009cited by this paper
• Inhibition of SUV39H1 Methyltransferase Activity by DBC1*

  2009cited by this paper
• Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer

  2009cited by this paper
• Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

  2009cited by this paper
• Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives

  2009cited by this paper
• Evidence for a biphasic apoptotic pathway induced by melatonin in MCF‐7 breast cancer cells

  2009cited by this paper
• Intratumoral Estrogens and Estrogen Receptors in Human Non–Small Cell Lung Carcinoma

  2008cited by this paper
• SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes

  2008cited by this paper
• Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line

  2008cited by this paper
• DBC1 is a negative regulator of SIRT1

  2008cited by this paper
• Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp‐9) and effector caspases (casp‐3/casp‐7) and PARP in UVR‐exposed HaCaT keratinocytes

  2008cited by this paper
• Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).

  2007cited by this paper
• Modulation of estrogen receptor alpha protein level and survival function by DBC-1.

  2007cited by this paper
• Medical implications of melatonin: receptor-mediated and receptor-independent actions.

  2007cited by this paper
• A protocol for rapid generation of recombinant adenoviruses using the AdEasy system

  2007cited by this paper
• Modulation of estrogen receptor α protein level and survival function by DBC-1

  2007cited by this paper
• Melatonin increases survival of HaCaT keratinocytes by suppressing UV‐induced apoptosis

  2006cited by this paper
• Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.

  2006cited by this paper
• Melatonin in cancer management: progress and promise.

  2006cited by this paper
• Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemiareperfusion: role of cardiolipin

  2006cited by this paper
• Melatonin prevents apoptosis induced by UV‐B treatment in U937 cell line

  2006cited by this paper
• Melatonin–estrogen interactions in breast cancer

  2005cited by this paper
• Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling

  2005cited by this paper
• Molecular tools to study melatonin pathways and actions.

  2005cited by this paper
• Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin‐induced oncostatic effects

  2005cited by this paper
• Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism

  2005cited by this paper
• Apoptosis in the development and treatment of cancer.

  2004cited by this paper
• Melatonin suppresses reactive oxygen species induced by UV irradiation in leukocytes

  2004cited by this paper
• Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.

  2003cited by this paper
• Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters

  2003cited by this paper
• Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture

  2003cited by this paper
• The chemistry of melatonin's interaction with reactive species

  2003cited by this paper
• Melatonin and mammary cancer: a short review.

  2003cited by this paper
• Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.

  2002cited by this paper
• Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.

  2002cited by this paper
• Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor α and β and Show Biological Responses to Estrogen

  2002cited by this paper
• MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.

  2002cited by this paper
• Expression of estrogen receptors α and β in human lung tissue and cell lines

  2002cited by this paper
• Melatonin: reducing the toxicity and increasing the efficacy of drugs

  2002cited by this paper
• Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat

  2001cited by this paper
• Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.

  1998cited by this paper
• A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients.

  1995cited by this paper
• Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells.

  1994cited by this paper
• QUARTERLY REVIEW

  1994cited by this paper
• The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.

  1992cited by this paper
• Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.

  1988cited by this paper

• CCAR2 Drives Glioma Cell Survival by Positively Regulating SIRT1 and Activating the Notch1/c‐Myc Pathway

  2025cites this paper
• CircKRT75 augments the cisplatin chemoresistance of nasopharyngeal carcinoma via targeting miR-659/CCAR2 axis

  2024cites this paper
• Protective effect of melatonin against methamphetamine-induced attention deficits through miR-181/SIRT1 axis in the prefrontal cortex

  2024cites this paper
• Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

  2023cites this paper
• The effect of 24-hour sleep deprivation and anaerobic exercise on the expression of BAX, BCL2, BMAL1 and CCAR2 genes in peripheral blood mononuclear cells after L-arginine supplementation.

  2023cites this paper
• An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress

  2021cites this paper
• Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities

  2021cites this paper
• CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis

  2020cites this paper
• Melatonin and non-small cell lung cancer: new insights into signaling pathways

  2019cites this paper
• Integrative Analysis of Cancer Omics Data for Prognosis Modeling

  2019cites this paper
• Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

  2018cites this paper
• Melatonin inhibits epithelial‑to‑mesenchymal transition in gastric cancer cells via attenuation of IL‑1β/NF‑κB/MMP2/MMP9 signaling.

  2018cites this paper
• Melatonin and sirtuins: A “not‐so unexpected” relationship

  2017cites this paper
• Melatonin for the prevention and treatment of cancer

  2017cites this paper
• CCAR2 negatively regulates IL-8 production in cervical cancer cells

  2017cites this paper
• Mitochondrial CCAR2/DBC1 is required for cell survival against rotenone-induced mitochondrial stress.

  2017cites this paper
• Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo

  2016cites this paper
• Melatonin as a potential anticarcinogen for non-small-cell lung cancer

  2016cites this paper
• Melatonin potentiates cisplatin‐induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells

  2015cites this paper
• Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway.

  2015cites this paper
• Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis

  2014cites this paper